Skip to main content
. 2014 Aug 7;20(29):10193–10201. doi: 10.3748/wjg.v20.i29.10193

Table 1.

Reported cases of gastric adenosquamous carcinoma

Author Year Country Gender Age (yr) Signs and symptoms Preop diagnosis Surgical procedure Tumor size (cm) Location Metastasis Staging Adjuvant treatment Prognosis
Rolleston and Trevor[12] 1905 - M 39 - - - - P - - - -
Lubarsch[12] 1906 - - - - - - - P - - - -
Herxheime[12] 1907 - - - - - - - P - - - -
Boedeker[12] 1926 - F 35 - - - - P - - - -
F 65 - - - - P - - - -
Oberling and Wolf[12] 1927 - F 67 - - - - P - - - -
Pasternackv[12] 1935 - M 48 - - - - P - - - -
Martin and Pollosson[12] 1936 - F 64 - - - - B - - - -
Takagi[12] 1937 - M 33 - - - - B - - - -
Scheffler and Falk[12] 1940 - M 74 - - - - B - - - -
Wood[12] 1943 - M 51 - - - - P - - - -
M 37 - - - - P - - - -
Strassman[12] 1946 - M 85 - - - - B - - - -
O'Brien and Meehan[12] 1950 - M 40 - - - - P - - - -
Milanes et al[12] 1950 - M 50 - - - - B - - - -
Bellagie and Dahlin[12] 1951 - M 42 - - - - B - - - -
M 49 - - - - B - - - -
Hirai et al[12] 1963 - M 37 - - - - B and P - - - -
Straus, Heschel and Fortmann[12] 1968 - F 70 - - - - P - - - -
Lee et al[1] 1970 SK M 43 A2, EP, HP, TS Sub-G + O A LN
Taira et al[13] 1976 J F 45 - - - - - - - - -
Fujitomi et al[14] 1983 J - - - - - - - - Bor IV - -
Jalif et al[15] 1984 S1 F 68 - - - - - - - - -
Sato et al[16] 1984 J F 76 - - TG + S - - - Bor III - -
Matsumoto et al[17] 1984 J M 56 UAD - TG 5.0 × 4.0 A and B LN Bor III - -
Masuda et al[18] 1985 J - 53 UAP ASC Sub-G - B - Bor III - -
3Horikawa et al[19] 1987 J F 56 - - - - - - EGC - -
3Johzaki et al[20] 1988 J F 78 - - Par-G - - - EGC - -
3Butov et al[21] 1989 R - - - - - - - - EGC - -
Shigematsu et al[22] 1989 J F 74 EP + AL - - - - LN Bor III - -
4Yamamoto et al[23] 1989 J M 61 - Sub-G - - L, L1 LN - - -
Honda et al[24] 1990 J M 57 UAP - - - Angle region - Grade II ASC - -
Tsukino et al[25] 1990 J M 61 - - - - - LN Bor IV - -
Kawabe et al[26] 1990 J - - - - - - Fornix and B - - - -
Coard et al[27] 1991 J and C - - - - - - - - - - -
Tenma et al[28] 1993 J M 51 - - TG post chemo - - -ve Bor III - -
Ito et al[29] 1993 J - - - - - - - - - - -
Cabello Rodríguez et al[30] 1994 S1 F 84 - - - - A - - - -
Toyota et al[6] 1996 J F 72 RHE - P - - - Bor 2 + EGC - -
3Yoshida et al[5] 1996 J M 66 EP SCC Par-DG 2.1 × 2.0 A L, LN - - Died 2 yr post op2
Manna et al[31] 1998 P M 55 - - - - - - - - -
Mori et al[32] 2000 J M 59 - - TG + H - RS L, LN - - Died 2 mo post H1
Blázquez et al[33] 2005 S1 F 56 CA - - - A - - - Died few days post op
Endo et al[7] 2005 J M 55 F and A1 ASC Par-G + D3 7.0 × 8.0 A LN, L2 T2N2M0 - -
Nomura et al[34] 2006 J F 62 A1 - DG B and A - LN T3N3M0 Neoadjuvant chemo -
Terada[35] 2009 J F 87 N and V SCC TG + C1 + S 10 × 8 × 7 - SM, LV Bor IV - Died 5 mo post op
F 77 EP SCC G 6 × 5 × 7 - SM, LV Bor III - Died 8 mo post op
Faria et al[2] 2010 P F 84 EP -ve Sub-G 8 × 5 × 1.1 A LN, L T3N1M1 - -
Fukuda et al[36] 2012 J M 70 - - TG + D2 + H - - L - - -
Ebi et al[8] 2012 J M 74 AP and M SCC Par-G - B LN Advanced type 3 S1 monotherapy Alive post op 2 yr 10 mo
Saito et al[37] 2013 J M 60 UBP ASC No surgery - B-A LN - DC-S1 Pt died 3 mo post chemo
3Kimura et al[41] 2013 J M 77 - - LADG - - LN; Recurrence in liver ECG S-1 and cisplatin (CDDP) Alive 14 mo post op
Harsha Ajoodhea et al (present case) 2013 C M 73 Fever ADC TLTG+D2 8 × 7.5 B-A -ve T4a N0 M0 Rand S1 Alive at 20 mo post op
1

Died of lymphangitis carcinomatosa of the lung 2 mo after right hepatectomy;

2

Died of liver failure due to multiple metastases 2 yr after operation;

3

Early gastric cancer;

4

Hypesthesia and pain in both legs, and progressive difficulty in walking. A1: Anemia; A2: Anorexia; AL: Appetite loss; CA: Chronic anemia; EP: Epigastric pain; HP: Hunger pain; F: Fatigue; V: Vomiting; N: Nausea; RHE: Routine health examination; TS: Tarry stool; M: Melena; UAP: Upper abdominal pain; UAD: Upper abdominal discomfort; J: Japan; S1: Spain; P: Portugal; M: Maroc; C: China; R: Russia; SK: South Korea; JC: Jamaica and Commonwealth Caribbean; S: Splenectomy; Sub-G: Subtotal gastrectomy; Par-G: Partial gastrectomy; P: Pylorogastrectomy; H: Hepatectomy; DG: Distal gastrectomy; C1: Cholecystectomy; ASC: Adenosquamous carcinoma; Par-DG: Partial distal gastrectomy; SSC: Squamous cell carcinoma; ADC: Adenocarcinoma; A: Antrum; B: Body; F: Fornix; C: Cardia; P: Pylorus; O: Omentectomy; RS: Remnant stomach; Borr: Borrmann type; L: liver; L1: Lung; SM: Systemic metastases; LN: Lymph node metastases; LV: Lymphovascular metastases; L2: Lymphatics; R: Radiotherapy; S1: S1 chemotherapy; DC-S1: Docetaxel, cisplatin and S-1 (DCS); EGC: Early gastric cancer; LADG: Laparoscopic-assisted distal gastrectomy; TLTG: Totally laparoscopic total gastrectomy.